- Home
- PLTK vs DYN Comparison
PLTK vs DYN Comparison
Compare PLTK & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLTK
- DYN
- Stock Information
- Founded
- PLTK 2010
- DYN 1984
- Country
- PLTK Israel
- DYN United States
- Employees
- PLTK N/A
- DYN N/A
- Industry
- PLTK EDP Services
- DYN Medicinal Chemicals and Botanical Products
- Sector
- PLTK Technology
- DYN Health Care
- Exchange
- PLTK Nasdaq
- DYN Nasdaq
- Market Cap
- PLTK 2.8B
- DYN 3.4B
- IPO Year
- PLTK 2021
- DYN 2020
- Fundamental
- Price
- PLTK $8.45
- DYN $28.39
- Analyst Decision
- PLTK Buy
- DYN Strong Buy
- Analyst Count
- PLTK 11
- DYN 9
- Target Price
- PLTK $9.18
- DYN $52.44
- AVG Volume (30 Days)
- PLTK 553.0K
- DYN 1.0M
- Earning Date
- PLTK 11-07-2024
- DYN 11-12-2024
- Dividend Yield
- PLTK 4.73%
- DYN N/A
- EPS Growth
- PLTK N/A
- DYN N/A
- EPS
- PLTK 0.58
- DYN N/A
- Revenue
- PLTK $2,536,900,000.00
- DYN N/A
- Revenue This Year
- PLTK $0.74
- DYN N/A
- Revenue Next Year
- PLTK $3.94
- DYN N/A
- P/E Ratio
- PLTK $14.55
- DYN N/A
- Revenue Growth
- PLTK N/A
- DYN N/A
- 52 Week Low
- PLTK $6.25
- DYN $9.82
- 52 Week High
- PLTK $9.23
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- PLTK 66.86
- DYN 42.04
- Support Level
- PLTK $7.75
- DYN $27.99
- Resistance Level
- PLTK $8.60
- DYN $35.68
- Average True Range (ATR)
- PLTK 0.23
- DYN 2.09
- MACD
- PLTK 0.05
- DYN 0.23
- Stochastic Oscillator
- PLTK 82.35
- DYN 9.12
About PLTK Playtika Holding Corp.
Playtika Holding Corp is primarily engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It primarily derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.